The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 327.00
Bid: 322.50
Ask: 330.00
Change: 0.00 (0.00%)
Spread: 7.50 (2.326%)
Open: 327.00
High: 327.00
Low: 327.00
Prev. Close: 327.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Numis cuts Kingfisher but raises Next

Tue, 11th Oct 2022 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

----------

FTSE 100

----------

Citigroup raises Centrica to 'buy' (neutral) - price target 81 (97) pence

----------

Citigroup raises Compass price target to 2,260 (2,170) pence - 'buy'

----------

Deutsche Bank raises Coca-Cola HBC target to 2,750 (2,700) pence - 'buy'

----------

Bernstein cuts Tesco price target to 250 (330) pence - 'outperform'

----------

Credit Suisse raises Anglo American target to 3,440 (3,290) pence - 'outperform'

----------

Credit Suisse cuts Antofagasta price target to 1,020 (1,040) pence - 'neutral'

----------

Credit Suisse raises Fresnillo price target to 650 (630) pence - 'underperform'

----------

Credit Suisse raises Rio Tinto price target to 5,800 (5,600) pence - 'outperform'

----------

Credit Suisse raises Glencore price target to 760 (720) pence - 'outperform'

----------

Credit Suisse cuts Severn Trent price target to 2,680 (2,800) pence - 'neutral'

----------

JPMorgan raises DS Smith price target to 388 (378) pence - 'overweight'

----------

Credit Suisse cuts Rightmove price target to 490 (608) pence - 'neutral'

----------

JPMorgan cuts Barclays price target to 180 (200) pence - 'neutral'

----------

JPMorgan cuts NatWest price target to 300 (350) pence - 'neutral'

----------

JPMorgan cuts Lloyds Banking price target to 56 (64) pence - 'overweight'

----------

Numis cuts Kingfisher to 'sell' (reduce) - price target 150 (215) pence

----------

Numis raises Next to 'buy' (add) - price target 6,800 (7,000) pence

----------

FTSE 250

----------

HSBC cuts Sirius Real Estate price target to 124 (138) pence - 'buy'

----------

JPMorgan cuts Virgin Money UK price target to 165 (200) pence - 'neutral'

----------

Barclays cuts Moneysupermarket.com target to 220 (230) pence - 'equal weight'

----------

Barclays cuts Future price target to 1,975 (2,500) pence - 'overweight'

----------

Berenberg cuts Marshalls price target to 280 (380) pence - 'hold'

----------

JPMorgan cuts Johnson Matthey price target to 2,150 (2,600) pence - 'neutral'

----------

Goldman Sachs cuts TI Fluid price target to 132 (179) pence - 'neutral'

----------

SMALL CAP

----------

Jefferies reinitiates ITM Power with 'buy' - price target 185 pence

----------

Jefferies reinitiates Ceres Power with 'hold' - price target 365 pence

----------

Citigroup cuts Ceres Power price target to 800 (1500) pence - 'buy'

----------

Barclays cuts Just Eat Takeaway target to 1,490 (1,940) pence - 'equal weight'

----------

RBC raises Oxford BioMedica price target to 1,110 (1,020) pence - 'outperform'

----------

Barclays starts Glenveagh Properties with 'overweight' - price target 1.20 EUR

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
16 Apr 2021 09:49

BROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone

BROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone

Read more
15 Apr 2021 09:02

Oxford Biomedica swings to EBITDA profit

(Sharecast News) - Oxford Biomedica reported a 37% improvement in total revenues in its preliminary results on Thursday, to £87.7m.

Read more
15 Apr 2021 09:00

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal

Read more
8 Apr 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
6 Apr 2021 08:19

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Read more
6 Apr 2021 08:08

Oxford Biomedica strikes three-year deal with Boehringer Ingelheim

(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a new three-year development and supply agreement with Boehringer Ingelheim, it announced on Tuesday, for the manufacture and supply of various types of viral vectors.

Read more
6 Apr 2021 07:53

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

Read more
21 Mar 2021 20:57

EU rebuffs UK calls to ship AstraZeneca COVID vaccines from Europe

By Francesco GuarascioBRUSSELS, March 21 (Reuters) - The European Union is rebuffing British government calls to ship AstraZeneca COVID-19 vaccines produced in a factory in the Netherlands, an EU official said on Sunday.Former EU member Britain ha...

Read more
19 Mar 2021 10:29

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Read more
19 Mar 2021 07:50

Oxford Biomedica says Sanofi pulling out of haemophilia project

(Sharecast News) - Oxford Biomedica said that Sanofi's decision to terminate collaboration on a haemophilia treatment would have a "negligible" impact on revenue.

Read more
3 Feb 2021 13:56

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

Read more
29 Jan 2021 09:11

UPDATE 1-EU holds out for more after AstraZeneca offered 8 mln extra COVID-19 shots

* Astra had committed to at least 80 mln shots in Q1* EU funded two UK plants under deal with Astra - sources* Astra says UK has priority for doses produced there (Adds detail, background)By Francesco Guarascio and Sabine SieboldBRUSSELS, Jan 29 (Re...

Read more
18 Jan 2021 17:18

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

Read more
8 Jan 2021 09:40

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

Read more
8 Dec 2020 12:31

UK's initial AstraZeneca shots will come from Europe, taskforce says

By Alistair SmoutLONDON, Dec 8 (Reuters) - Britain's initial doses of the COVID-19 vaccine candidate developed by AstraZeneca and Oxford University will come from Europe rather than a domestic supply chain, the country's Vaccine Taskforce said.The...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.